New Methodological Approaches to Assess Value of Immuno-Oncology Therapies

Boston, MA—MAY 24, 2017—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) hosted a morning session at its 22nd Annual International Meeting in Boston, MA, USA that examined cost-effectiveness models for innovative oncology treatments. Read more ›

Posted in Announcements, ISPOR News & Press Tagged with: , ,

The 21st Century Cures Act: Considering the Implications

Boston, MA—May 23, 2017—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) held several sessions at its 22nd Annual International Meeting in Boston, MA, USA this afternoon that discussed regulatory and health policy implications of the 21st Century Cures Act. Read more ›

Posted in Announcements, ISPOR News & Press Tagged with: ,

Short- and Long-Term Impact of Medicare Negotiating Drug Prices: A Critical Look at the Policy Proposals

Boston, MA—May 23, 2017—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) hosted a session that explored the economic impact of Medicare directly negotiating drug prices for enrollees. The session was held this afternoon at ISPOR’s 22nd Annual International Meeting in Boston, MA, USA. Read more ›

Posted in Announcements, ISPOR News & Press Tagged with: , ,

The Power of Social Network Interventions on Population Health

Dr. Nicholas Christakis Presented Research on How Social Contagion Interventions Could Impact Health Care
 

Boston, MA—May 23, 2017—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) held its second plenary session this morning at its 22nd Annual International Meeting in Boston, MA, USA. The plenary, Social Network Interventions and Population Health, highlighted the research of Nicholas A. Christakis, MD, PhD, MPH, Sol Goldman Professor, Social and Natural Science, Co-Director, Yale Institute for Network Science, Yale University, New Haven, CT, USA. The plenary was moderated by Shelby D. Reed, PhD, RPh, Professor, Duke University, Durham, NC, USA and ISPOR President-Elect.   Read more ›

Posted in Announcements, ISPOR News & Press Tagged with: , ,

The Relationship Between Cost Effectiveness and Affordability in Health Care

A Look at How Innovative, High-Cost Therapies Stress Payer Budgets

 

Boston, MA—May 23, 2017—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) hosted a session this morning at its 22nd Annual International Meeting in Boston, MA, USA that examined the relationship between cost effectiveness and affordability of health care therapies. Read more ›

Posted in Announcements, ISPOR News & Press Tagged with: ,

Assessment of Value in Health Care

New Information on ISPOR’s Initiative on US Value Assessment Frameworks

 

Boston, MA—May 22, 2017—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) held two scientific sessions on value assessment frameworks this afternoon at its 22nd Annual International Meeting in Boston, MA, USA. Read more ›

Posted in Announcements, ISPOR News & Press Tagged with: , , ,

Capturing the “Patient Voice” in Health Care

Presentation Explores Methods to Best Quantify Patient Input

Boston, MA—May 22, 2017—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) hosted a session at its 22nd Annual International Meeting that explored what methods researchers and health technology assessors should employ to best capture the patient voice in HEOR research. Read more ›

Posted in Announcements, ISPOR News & Press Tagged with: , ,

ISPOR and ISPE Collaborate to Advance Good Practices for Use of Real-World Evidence

Societies Join Forces with Special Task Force on Real-World Evidence in Health Care Decision Making


Boston, MA
—May 22, 2017—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) and the International Society for Pharmacoepidemiology (ISPE) have joined forces to collaborate on a Special Task Force on real-world evidence in regulatory decision making. This initiative was the focus of an invited issue panel this morning at the ISPOR 22nd Annual International Meeting in Boston, MA, USA. Read more ›

Posted in Announcements, ISPOR News & Press Tagged with: , , ,

Opening Plenary Session Explores Direction of US Health Policy Changes

Four Prominent Health Economists Debated the Future of Health Care in the United States

 

Boston, MA—May 22, 2017—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) opened its 22nd Annual International Meeting in Boston, MA, USA this morning with its first plenary session, Where Is US Health Policy Going?. Read more ›

Posted in Announcements, ISPOR News & Press Tagged with: , , ,

ISPOR 22nd Annual International Meeting to Focus on Social and Policy Change in Health Care

Conference to Be Held May 20-24, 2017 in Boston

Princeton, NJ—May 9, 2017—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR), the leading educational and scientific organization for health economics and outcomes research (HEOR), announced confirmation of the scientific sessions for its upcoming 22nd Annual International Meeting in Boston, MA, USA. Read more ›

Posted in Announcements, ISPOR News & Press Tagged with: , , , , , , , , , , , ,